Implementation of sentinel lymph node biopsy for XXXX by surgeons in the Department of Defense.

@entity1 @entity0 @entity1600 @entity12670 @entity599 @entity25739
BACKGROUND: @entity1600 ( @entity1600 ) for the evaluation of @entity1 with @entity0 is rapidly gaining acceptance. The purpose of this study was to assess how surgeons in the Department of Defense ( @entity25739 ) are incorporating @entity1600 into practice. METHODS: Surgeons at all @entity25739 hospitals were telephonically surveyed regarding their current practices with @entity1600 . RESULTS: Of 66 @entity25739 hospitals 23 (35%) are currently performing @entity1600 . Eleven hospitals (11 of 23, 48%) are academic centers, while 12 (12 of 23, 52%) are not teaching facilities. Seventeen (17 of 23, 77%) are in the learning phase of @entity1600 and follow @entity1600 with an axillary dissection. Eighteen (18 of 23, 78%) of facilities have surgeons who learned the procedure in residency/fellowship training. Sixteen (16 of 23, 70%) use a combination of @entity12670 dye and @entity599 colloid radioisotope. Surgeons performing @entity1600 are not aware of the method of examination of the sentinel node at their institution at 6 of 23 (26%) of hospitals. CONCLUSIONS: Increasing numbers of surgeons in the @entity25739 Healthcare System are performing @entity1600 . The majority learned the procedure in residency or fellowship and are using a combination of blue dye and radioisotope for the performance of @entity1600 .
